Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lentinula edodes (Lentinan).
Lentinan is a high-molecular-weight β-(1→3)-glucan with β-(1→6)-branches that exerts potent immunomodulatory effects by activating cytotoxic T-lymphocytes and natural killer cells through the Dectin-1 receptor pathway.
37736
265.3 g/mol
3
5,6-diphenyl-1,2,4-triazine-3-thiol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lentinula edodes (Lentinan) across standard consumer modalities.
The hygroscopic nature of concentrated Lentinan extracts requires moisture-resistant HPMC shells to prevent clumping and maintain long-term stability.
High concentrations of β-glucans can interfere with pectin cross-linking, potentially resulting in a rubbery texture or syneresis in the final gummy matrix.
The high therapeutic dose required for Lentinan significantly exceeds the typical 20-50mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Lentinula edodes (Lentinan)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lentinula edodes (Lentinan) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lentinula edodes (Lentinan) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation